By: Jordyn Sava From: targetedonc.com In a study examining racial disparities, differences in curative intent, endocrine and/or chemotherapy, frequency and types of treatment-related adverse events, and more were seen in Non-Hispanic Black women vs Non-Hispanic White women with breast cancer Non-Hispanic Black women with breast cancer are less likely to undergo curative intent surgery or receive endocrine therapy than non-Hispanic …
Model predicts risk for immune-related adverse events in breast cancer subset
From: healio.com A symptom pattern model predicted risk for immune-related adverse events among women with early-stage, high-risk breast cancer, according to an analysis of the phase 2 I-SPY2 trial presented at San Antonio Breast Cancer Symposium. The findings could help clinicians be more diligent with monitoring during active treatment and after therapy, researchers concluded. Background and methods “Immune checkpoint inhibitors …
Women of All Ages with Breast Cancer Experience the Same Levels of Symptom Severity
By: Colleen Moretti From: curetoday.com Both older and younger women with early breast cancer (EBC) being treated with the same chemotherapy experienced around the same levels of symptom severity and symptom-related adverse events, according to a study published in Cancer. It was unknown whether there was patient-reported symptom severity and symptom interference with daily activities difference in women under the …
Managing Systemic Toxicities and Limiting Therapy Non-Adherence in Breast Cancer
By: Hayley Virgil From: onclive.com One of the most important tasks that oncology nurses face is ensuring that patients are taking their medications consistently and correctly, and that adverse events are properly managed—specifically in those patients with breast cancer. One of the most important tasks that oncology nurses face is ensuring that patients are taking their medications consistently and correctly, …
Impact of Pharmacist Management of Oral Chemotherapy for Patients in an Outpatient Breast Cancer Clinic
By: Alana Hippensteele, Editor From: pharmacytimes.com In outpatient breast cancer clinics, oral chemotherapies are becoming more common as a treatment method for various malignancies. Yet, the hematologic (eg neutropenia) and non-hematologic (eg diarrhea) toxicities that patients experience while taking these oral chemotherapies can cause increased clinic visits, delays in treatment, and non-adherence to treatment, according to a poster presented by …